Antiretroviral Treatment of HIV/AIDS During Pregnancy.
作者信息
Eke Ahizechukwu C, Lockman Shahin, Mofenson Lynne M
机构信息
Division of Maternal Fetal Medicine, Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
JAMA. 2023 Apr 18;329(15):1308-1309. doi: 10.1001/jama.2023.5076.
Abstract
摘要
相似文献
1
Antiretroviral Treatment of HIV/AIDS During Pregnancy.孕期抗逆转录病毒治疗艾滋病毒/艾滋病
JAMA. 2023 Apr 18;329(15):1308-1309. doi: 10.1001/jama.2023.5076.
2
Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.撒哈拉以南非洲地区接受抗逆转录病毒疗法的人类免疫缺陷病毒感染孕妇的药物依从性：系统评价。
BMC Public Health. 2018 Jun 27;18(1):805. doi: 10.1186/s12889-018-5651-y.
3
Antiretroviral use during pregnancy for treatment or prophylaxis.妊娠期抗逆转录病毒治疗或预防应用。
Expert Opin Pharmacother. 2011 Aug;12(12):1875-85. doi: 10.1517/14656566.2011.584062. Epub 2011 May 3.
4
Antiretroviral treatment of maternal HIV infection.孕产妇艾滋病毒感染的抗逆转录病毒治疗。
Can Fam Physician. 2004 Jun;50:865-8.
5
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
6
Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.抗逆转录病毒药物——如何最好地保护婴儿免受艾滋病毒感染并使他们的母亲免于患艾滋病。
N Engl J Med. 2004 Jul 15;351(3):289-92. doi: 10.1056/NEJMe048128. Epub 2004 Jul 9.
7
U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.美国公共卫生服务部特别工作组关于在感染HIV-1的孕妇中使用抗逆转录病毒药物以促进孕产妇健康及采取干预措施减少美国围产期HIV-1传播的建议。
MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.
8
A review on infection with human immunodeficiency virus.关于人类免疫缺陷病毒感染的综述。
Best Pract Res Clin Obstet Gynaecol. 2006 Dec;20(6):923-40. doi: 10.1016/j.bpobgyn.2006.06.002. Epub 2006 Aug 7.
9
Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement.HIV 感染筛查：美国预防服务工作组推荐声明。
JAMA. 2019 Jun 18;321(23):2326-2336. doi: 10.1001/jama.2019.6587.
10
Mini review: Prevention of mother-child transmission of HIV: 25 years of continuous progress toward the eradication of pediatric AIDS?综述：预防母婴传播 HIV：在消除儿科艾滋病的道路上 25 年的持续进步？
Virulence. 2020 Dec;11(1):14-22. doi: 10.1080/21505594.2019.1697136.
引用本文的文献
1
Considerable variation in the 95-95-95 targets accomplishment between children and adults might delay achievement of set targets.儿童和成人在95-95-95目标达成方面存在相当大的差异，这可能会延迟既定目标的实现。
Front Public Health. 2025 Apr 29;13:1565242. doi: 10.3389/fpubh.2025.1565242. eCollection 2025.
2
Rising global burden of common gynecological diseases in women of childbearing age from 1990 to 2021: an update from the Global Burden of Disease Study 2021.1990年至2021年育龄女性常见妇科疾病的全球负担上升：《2021年全球疾病负担研究》的最新情况
Reprod Health. 2025 Apr 21;22(1):57. doi: 10.1186/s12978-025-02013-1.
3
Safety, Tolerability, and Pharmacokinetics of Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC07-523LS in Newborn Infants Exposed to HIV-1.长效广泛中和HIV-1单克隆抗体VRC07-523LS在暴露于HIV-1的新生儿中的安全性、耐受性和药代动力学
J Pediatric Infect Dis Soc. 2025 Feb 6;14(2). doi: 10.1093/jpids/piaf002.
4
Pharmacokinetics and Safety of Bictegravir in Pregnant and Postpartum Persons With HIV and Their Infants.比克替拉韦在感染HIV的孕妇、产后妇女及其婴儿中的药代动力学和安全性
J Acquir Immune Defic Syndr. 2025 Mar 1;98(3):300-307. doi: 10.1097/QAI.0000000000003571.
5
Research on Maternal Vaccination for HIV Prevention.预防艾滋病的母婴疫苗接种研究。
Clin Perinatol. 2024 Dec;51(4):769-782. doi: 10.1016/j.clp.2024.08.007. Epub 2024 Sep 11.
6
Care of Pregnant Women Living with Human Immunodeficiency Virus.艾滋病病毒感染孕妇的护理。
Clin Perinatol. 2024 Dec;51(4):749-767. doi: 10.1016/j.clp.2024.08.010.
7
Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy.接受基于替诺福韦的抗逆转录病毒治疗的HIV感染孕妇的血脂和血糖状况
Clin Infect Dis. 2025 Mar 17;80(3):594-601. doi: 10.1093/cid/ciae441.
8
Comparison of safety and effectiveness of antiretroviral therapy regimens among pregnant women living with HIV at preconception or during pregnancy: a systematic review and network meta-analysis of randomized trials.比较孕前或孕期 HIV 感染孕妇的抗逆转录病毒治疗方案的安全性和有效性：一项随机试验的系统评价和网络荟萃分析。
BMC Infect Dis. 2024 Apr 19;24(1):417. doi: 10.1186/s12879-024-09303-2.
9
Gestational Viral Infections: Role of Host Immune System.妊娠期病毒感染：宿主免疫系统的作用
Microorganisms. 2023 Jun 22;11(7):1637. doi: 10.3390/microorganisms11071637.
10
Comparison of Efavirenz and Doravirine Developmental Toxicity in an Embryo Animal Model.比较依非韦伦和多拉韦林在胚胎动物模型中的发育毒性。
Int J Mol Sci. 2023 Jul 19;24(14):11664. doi: 10.3390/ijms241411664.
本文引用的文献
1
Children who are HIV-exposed and uninfected: evidence for action.HIV 暴露但未感染的儿童：采取行动的证据。
AIDS. 2023 Feb 1;37(2):205-215. doi: 10.1097/QAD.0000000000003409.
2
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.抗逆转录病毒药物治疗和预防成人 HIV 感染：美国国际抗病毒学会 2022 年推荐意见。
JAMA. 2023 Jan 3;329(1):63-84. doi: 10.1001/jama.2022.22246.
3
Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery.法国围产期人类免疫缺陷病毒 1 型传播的更新：5482 名从受孕开始接受连续抗逆转录病毒治疗且分娩时病毒载量不可检测的母亲无传播。
Clin Infect Dis. 2023 Feb 8;76(3):e590-e598. doi: 10.1093/cid/ciac703.
4
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.多替拉韦与恩曲他滨和富马酸替诺福韦艾拉酚胺或富马酸替诺福韦二吡呋酯，以及依非韦伦、恩曲他滨和富马酸替诺福韦二吡呋酯用于孕期启动的HIV抗逆转录病毒治疗方案的疗效和安全性（IMPAACT 2010/VESTED）：一项多中心、开放标签、随机、对照、3期试验。
Lancet. 2021 Apr 3;397(10281):1276-1292. doi: 10.1016/S0140-6736(21)00314-7.
5
Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint.含考比司他的抗逆转录病毒治疗方案不建议在妊娠期使用：观点。
AIDS. 2019 May 1;33(6):1089-1093. doi: 10.1097/QAD.0000000000002163.
6
Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus.患有人类免疫缺陷病毒的孕妇和哺乳期妇女进行前瞻性研究的重要性。
Clin Infect Dis. 2019 Sep 13;69(7):1254-1258. doi: 10.1093/cid/ciz121.
7
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial.预防 HIV-1 通过母乳喂养传播：在高 CD4 细胞计数的 HIV-1 感染妇女中，母亲抗逆转录病毒治疗与婴儿奈韦拉平预防持续母乳喂养时长的效果和安全性（IMPAACT PROMISE）：一项随机、开放标签、临床试验。
J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):383-392. doi: 10.1097/QAI.0000000000001612.
8
Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.孕期抗逆转录病毒治疗方案的比较安全性
JAMA Pediatr. 2017 Oct 2;171(10):e172222. doi: 10.1001/jamapediatrics.2017.2222.
9
Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?孕期中断抗逆转录病毒治疗是否是1型艾滋病毒母婴传播的另一个主要危险因素？
Clin Infect Dis. 2009 May 1;48(9):1310-7. doi: 10.1086/597774.
Zotero 插件